Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Inhibitex Investors: Why Shares Popped 115%
Inhibitex Investors: Why Shares Popped 115%
Inhibitex Investors: Why Shares Popped 115%
Submitted by
admin
on November 6, 2011 - 11:57am
Source:
Motley Fool
News Tags:
Inhibitex
INX-189
hepatitis C
Headline:
Inhibitex Investors: Why Shares Popped 115%
Do Not Allow Advertisers to Use My Personal information
